Corticosteroid in treatment of acute laryngitis among vocal professionals

Status

Not yet recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-512192-12-00

Enrollment

Registered

2024-10-29

Start date

Unknown

Completion date

Unknown

Last updated

2024-10-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute laryngitis

Brief summary

The duration of the vocal symptoms

Detailed description

Inflammatory findings of larynx (especially in vocal cords) in laryngoscopy

Interventions

DRUGWhite

DRUGflat round

DRUGuncoated tablet. Diameter 9 mm.

DRUGPrednisolon 20 mg tabletit

Eligibility

Sex/Gender

All

Age

18 Years to 64 Years

Design outcomes

Primary

Measure	Time frame
The duration of the vocal symptoms	—

Secondary

Measure	Time frame
Inflammatory findings of larynx (especially in vocal cords) in laryngoscopy	—

Countries

Finland

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026